Skip to main content
. 2023 May 21;12(5):936. doi: 10.3390/antibiotics12050936

Table 1.

Baseline demographic characteristics of patients.

Number of Patients (Percentage)
Age range (mean)—years 18–84 (63.6)
Female 7 (31.8)
Male 15 (68.2)
Hypertension 13 (59.1)
Hyperlipidemia 10 (45.5)
Diabetes 10 (45.5)
PVD 5 (22.7)
CVA/TIA/Chronic CNS complications (i.e., subdural hematoma, anoxic brain injury) 6 (27.3)
Chronic kidney disease (CKD) 4 (18.2)
End-stage renal disease (ESRD) on dialysis 2 (9.1)
Chronic heart disease (i.e., CAD, Afib, CHF) 12 (54.5)
Chronic lung disease (i.e., COPD, pulmonary fibrosis, cystic fibrosis, chronic respiratory failure) 7 (31.8)
Chronic liver disease (i.e., cirrhosis, NAFLD, autoimmune hepatitis) 2 (9.1)
Malignancy 3 (13.6)
Organ transplant 2 (9.1)
HIV 1 (4.5)
AIDS 0
Connective tissue disease 1 (4.5)
Charlson comorbidity index score range (mean) 0–11 (5.4)
Length of stay range (mean)—days 11–220 (53)

PVD: peripheral vascular disease, CVA: cerebrovascular accident, TIA: transient ischemic attack, CNS: central nervous system, CAD: coronary artery disease, Afib: atrial fibrillation, CHF: congestive heart failure, COPD: chronic obstructive pulmonary disease, NAFLD: nonalcoholic fatty liver disease, HIV: human immunodeficiency virus, and AIDS: acquired immunodeficiency syndrome.